Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016109 |
---|---|
Receipt number | R000018713 |
Scientific Title | Evaluation of Oral Care in preventing Oral Mucositis in Estrogen Receptor Positive Metastatic Breast Cancer Patients Treated with Everolimus: Randomized Controlled Phase III Trial |
Date of disclosure of the study information | 2015/01/05 |
Last modified on | 2019/10/18 13:46:57 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/01/05 11:24:50 | ||
2 | Update | 2015/01/05 11:32:33 | Date of disclosure of the study information |
|
3 | Update | 2015/01/05 15:33:15 | Public title |
|
4 | Update | 2015/02/24 16:02:41 | Recruitment status Anticipated trial start date |
|
5 | Update | 2015/04/15 15:32:29 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
6 | Update | 2015/07/29 10:46:49 | Anticipated trial start date |
|
7 | Update | 2017/01/16 16:52:28 | Study type Key inclusion criteria Key inclusion criteria |
|
8 | Update | 2017/01/16 16:53:30 | Last follow-up date |
|
9 | Update | 2017/08/22 13:41:30 | Name of primary person or sponsor Organization Institutions |
|
10 | Update | 2017/11/15 16:57:39 | Institutions |
|
11 | Update | 2018/10/03 17:02:58 | Recruitment status |
|
12 | Update | 2018/10/24 10:51:01 | Public title |
|
13 | Update | 2018/10/24 11:01:08 | Organization Organization Organization Category of Funding Organization |
|
14 | Update | 2019/01/09 16:46:21 | Recruitment status |
|
15 | Update | 2019/10/18 13:46:57 | Date of IRB Date of closure to data entry Date trial data considered complete |